CVS
CVS Health Corp.
$97.23
-0.37
(-0.38%)
Mkt Cap
124.06B
Volume
5,401,221
52W Range
69.51-110.68
Sector
Healthcare
Beta
0.60
EPS (TTM)
3.83 USD
P/E Ratio
25.39
Revenue (TTM)
415.09B USD
Rev Growth (5Y)
+8.4%
EPS Growth (5Y)
-23.9%
AlphaVal · Fair Value
What we estimate one share is worth
$64.74
Overvalued
strong signal
50.2% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
C-
Stable Earnings Power
45.8 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.
Company Description
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 402.07B | 372.81B | 357.78B | 322.47B | 292.11B | 268.71B | 256.78B | 194.58B | 184.79B | 177.55B | 153.29B | 139.37B |
| Net Income | 1.77B | 4.61B | 8.34B | 4.31B | 8.00B | 7.18B | 6.63B | (594.00M) | 6.62B | 5.32B | 5.24B | 4.64B |
| EPS | 1.40 | 3.66 | 6.49 | 3.29 | 6.00 | 5.48 | 5.10 | -0.57 | 6.47 | 4.93 | 4.66 | 3.98 |
| Free Cash Flow | 7.81B | 6.33B | 10.39B | 13.45B | 15.74B | 13.43B | 10.39B | 6.83B | 6.09B | 7.92B | 6.17B | 6.00B |
| FCF / Share | 6.16 | 5.02 | 8.09 | 10.25 | 11.94 | 10.26 | 7.99 | 6.54 | 5.97 | 7.38 | 5.52 | 5.17 |
| Operating CF | 10.64B | 9.11B | 13.43B | 16.18B | 18.27B | 15.87B | 12.85B | 8.87B | 8.01B | 10.14B | 8.54B | 8.14B |
| Total Assets | 261.06B | 253.22B | 249.73B | 228.28B | 233.00B | 230.72B | 222.45B | 196.46B | 95.13B | 94.46B | 92.44B | 74.19B |
| Total Debt | 93.59B | 82.92B | 79.39B | 70.73B | 76.00B | 85.04B | 89.00B | 73.43B | 27.00B | 27.53B | 27.46B | 12.89B |
| Cash & Equiv | 8.51B | 8.59B | 8.20B | 12.95B | 9.41B | 7.85B | 5.68B | 4.06B | 1.70B | 3.37B | 2.46B | 2.48B |
| Book Value | 75.21B | 75.56B | 76.46B | 71.47B | 75.08B | 69.39B | 63.86B | 58.23B | 37.69B | 36.83B | 37.20B | 37.96B |
| Return on Equity | 0.02 | 0.06 | 0.11 | 0.06 | 0.11 | 0.10 | 0.10 | -0.01 | 0.18 | 0.14 | 0.14 | 0.12 |
| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 106.10B | 100.43B | 105.69B | 102.87B | 98.92B | 94.59B | 97.71B | 95.43B | 91.23B | 88.44B | 93.81B | 89.76B |
| Net Income | 3.00B | 2.94B | 2.94B | (3.98B) | 1.02B | 1.78B | 1.64B | 87.00M | 1.77B | 1.11B | 2.05B | 2.26B |
| EPS | 2.33 | 2.31 | 2.32 | -3.13 | 0.81 | 1.41 | 1.31 | 0.07 | 1.41 | 0.88 | 1.59 | 1.76 |
| Free Cash Flow | 5.65B | 3.40B | 2.61B | 98.00M | 1.29B | 3.81B | 1.09B | (1.42B) | 2.45B | 4.20B | (3.55B) | 2.17B |
| FCF / Share | 4.43 | 2.67 | 2.05 | 0.08 | 1.02 | 3.02 | 0.87 | -1.12 | 1.95 | 3.33 | -2.75 | 1.69 |
| Operating CF | 6.34B | 4.25B | 3.39B | 796.00M | 1.90B | 4.56B | 1.86B | (745.00M) | 3.09B | 4.90B | (2.64B) | 2.72B |
| Total Assets | 253.77B | 252.97B | 261.06B | 255.33B | 258.34B | 255.59B | 253.22B | 252.43B | 252.48B | 249.74B | 249.73B | 251.31B |
| Total Debt | 76.31B | 78.34B | 93.59B | 81.75B | 82.72B | 81.21B | 82.92B | 82.70B | 83.82B | 81.79B | 79.39B | 80.10B |
| Cash & Equiv | 11.33B | 9.54B | 8.51B | 9.15B | 11.79B | 10.08B | 8.59B | 6.88B | 12.51B | 9.80B | 8.20B | 13.04B |
| Book Value | 79.70B | 77.46B | 75.21B | 72.93B | 77.38B | 76.93B | 75.56B | 74.94B | 74.93B | 73.97B | 76.46B | 74.34B |
| Return on Equity | 0.04 | 0.04 | 0.04 | -0.05 | 0.01 | 0.02 | 0.02 | 0.00 | 0.02 | 0.02 | 0.03 | 0.03 |
CVS News
Did CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders?
Did CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders?
Here's How CVS' Improving Balance Sheet Supports Deleveraging
Why CVS Stock Rallied Tuesday Morning
CVS vs. UNH: Which Health Insurance Stock Has More Upside Now?
Wall Street Isn't Giving Up on CVS Health -- and Its Valuation Looks Stronger Than Investors Think
Why CVS Health (CVS) is a Top Value Stock for the Long-Term
How CVS' Pharmacy & Consumer Wellness Is Positioned for H2 2026
CVS Pharmacy® and MinuteClinic® now offering updated flu vaccines nationwide
Which Turnaround Is Better for Retirees: CVS or INTC?